NCT00779831View on ClinicalTrials.gov

Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

120 mg Pseudoephedrine hydrochloride extended release tablets

Trial Locations (1)

H4R2N6

MDS Pharma Services, Saint-Laurent

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00779831 - Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter